Blog - Vital Signs - Life Science Business Development & Finance

Blog for Life Science Business Development & Finance

Posts about

Glaxo

Biotech, Glaxo

A 29-year-old former Wall Streeter bought an Alzheimer's drug that failed clinical trials — and now his company is worth $3 billion

2 minute read

Securities are offered through Finalis Securities LLC Member FINRA/SIPC. S. Jordan Associates and Finalis Securities LLC are separate, unaffiliated entities. www.sjordanassociates.com (the "S. Jordan Associates Website") is a website operated by S. Jordan Associates, a privately held Illinois limited liability company. S. Jordan Associates provides e.g., financial and strategic advisory, consulting services, mergers and acquisitions services, fairness opinions, etc.

The Business Continuity Plan and Privacy Policy of Finalis, contained on www.finalis.com • FINRA Broker Check — www.finalis.com.